Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$107,922,182
-$27,041,785 QoQ
Shares Held
912,970
-14.9% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 55.558233019704915.ToString("F0")%
Shared 0.ToString("F0")%
None 44.441766980295085.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026LAZARD ASSET MANAGEMENT LLC holds $165,612,539 across 22 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (65.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
912,970 | $107,922,182 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
124,479 | $16,398,863 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
1,059,831 | $14,678,659 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
145,811 | $8,064,806 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
10,232 | $6,067,371 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
90,154 | $2,157,385 | |
| 7 | CGC |
Canopy Growth Corp
|
1,807,986 | $1,715,778 | |
| 8 | ESPR |
Esperion Therapeutics, Inc.
|
580,705 | $1,591,131 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $107,922,182 | 912,970 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $134,963,967 | 1,072,675 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $377,143,749 | 2,577,527 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $421,362,083 | 2,701,905 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $429,333,599 | 2,607,553 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $433,660,839 | 2,661,639 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $559,801,602 | 2,865,194 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $566,017,451 | 3,264,983 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $469,202,237 | 2,772,899 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $562,552,261 | 2,850,242 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $487,884,804 | 2,804,258 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $485,322,392 | 2,818,201 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $456,636,292 | 2,743,549 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $410,911,689 | 2,803,901 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $437,218,530 | 2,948,402 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $511,640,724 | 2,976,559 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $629,473,060 | 3,337,786 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $852,220,355 | 3,492,277 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $709,874,073 | 3,656,506 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $685,810,762 | 3,680,032 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $562,515,409 | 3,571,980 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $576,502,037 | 3,483,396 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $561,415,439 | 3,394,905 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $423,317,382 | 3,089,006 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $329,216,237 | 2,797,317 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||